RG
Rathbones Group’s Galectin Therapeutics GALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-16,400
| Closed | -$78K | – | 310 |
|
|
2018
Q1 | $78K | Hold |
16,400
| – | – | ﹤0.01% | 301 |
|
|
2017
Q4 | $55K | Hold |
16,400
| – | – | ﹤0.01% | 309 |
|
|
2017
Q3 | $35K | Hold |
16,400
| – | – | ﹤0.01% | 307 |
|
|
2017
Q2 | $40K | Hold |
16,400
| – | – | ﹤0.01% | 307 |
|
|
2017
Q1 | $38K | Hold |
16,400
| – | – | ﹤0.01% | 317 |
|
|
2016
Q4 | $16K | Hold |
16,400
| – | – | ﹤0.01% | 311 |
|
|
2016
Q3 | $19K | Hold |
16,400
| – | – | ﹤0.01% | 309 |
|
|
2016
Q2 | $24K | Hold |
16,400
| – | – | ﹤0.01% | 303 |
|
|
2016
Q1 | $23K | Hold |
16,400
| – | – | ﹤0.01% | 300 |
|
|
2015
Q4 | $21K | Hold |
16,400
| – | – | ﹤0.01% | 293 |
|
|
2015
Q3 | $38K | Hold |
16,400
| – | – | ﹤0.01% | 299 |
|
|
2015
Q2 | $45K | Hold |
16,400
| – | – | ﹤0.01% | 315 |
|
|
2015
Q1 | $55K | Hold |
16,400
| – | – | ﹤0.01% | 319 |
|
|
2014
Q4 | $57K | Hold |
16,400
| – | – | ﹤0.01% | 317 |
|
|
2014
Q3 | $82K | Buy |
+16,400
| New | +$82K | 0.01% | 294 |
|